Top

International Journal of Public Health

Published in:

01-09-2020 | Human Papillomavirus | Review

Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review

Authors: Saba Abidi, Satyanarayana Labani, Aastha Singh, Smita Asthana, Puneeta Ajmera

Published in: International Journal of Public Health | Issue 7/2020

Abstract

Objectives

Many reviews have been conducted on the economic evaluation of the HPV vaccine in global north countries. But there is a dearth of such reviews in the Global South countries. Hence, this systematic review aims to summarize studies done in these countries.

Methods

Four databases PubMed, Embase, Cochrane Library, and Google Scholar from 2009 to 2019 were searched for economic evaluations on HPV vaccination in the Global South countries. PRISMA guidelines were followed to include full-text articles. 40 original articles were shortlisted for full-text review.

Results

Studies had varied models, assumptions, and results according to different scenarios. Most studies concluded HPV vaccination to be cost-effective under varied scenarios and vaccine cost was the most influential parameter affecting the sensitivity analyses, consequently incremental cost-effectiveness ratio. A wide range in the cost-effectiveness ratio was observed in the included studies due to different study settings, populations, and inconsistencies in modeling practices (variations in methodological approaches).

Conclusions

This review suggests the introduction of HPV vaccination alone or in combination with screening according to different countries. The price of the vaccine should be economical and funds for the vaccine should be provided by public sector firms.

Available only for authorised users

Aguilar M, Otilia L, García O et al (2015) Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Vaccine 33:A167–A173. https://doi.org/10.1016/j.vaccine.2014.12.067CrossRefPubMed

Aljunid S, Maimaiti N, Nur AM et al (2016) Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia. BMC Public Health. https://doi.org/10.1186/s12889-016-2754-1CrossRefPubMedPubMedCentral

Aponte-González J, Fajardo-bernal L, Diaz J, Eslava-schmalbach J (2013) Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia. PLoS ONE 8:1–14. https://doi.org/10.1371/journal.pone.0080639CrossRef

Bardach AE, Garay OU, Calderón M et al (2017) Health economic evaluation of human papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model. BMC Public Health. https://doi.org/10.1186/s12889-017-4064-7CrossRefPubMedPubMedCentral

Ben Hadj Yahia MB, Jouin-Bortolotti A, Dervaux B (2015) Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies. Clin Drug Investig 35:471–485. https://doi.org/10.1007/s40261-015-0308-4CrossRefPubMed

Brisson M, Van De Velde N, Boily MC (2009) Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genom 12:343–351. https://doi.org/10.1159/000214924CrossRef

Burd E (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16: 1–17. http://www.sciencedirect.com/science/article/pii/S0140673607614160. https://doi.org/10.1128/CMR.16.1.1

Burger EA, Campos NG, Sy S et al (2018) Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. https://doi.org/10.1016/j.vaccine.2018.04.061CrossRefPubMedPubMedCentral

Campos NG, Kim JJ, Castle PE et al (2012) Cervical cancer screening in Eastern Africa. Int J Cancer 2684:2672–2684. https://doi.org/10.1002/ijc.26269CrossRef

Chanthavilay P, Reinharz D, Mayxay M et al (2016a) Economic evaluation of screening strategies combined with HPV vaccination of preadolescent girls for the prevention of cervical cancer in Vientiane. Lao PDR BMC Health Serv Res. https://doi.org/10.1371/journal.pone.0162915CrossRefPubMed

Chanthavilay P, Reinharz D, Mayxay M et al (2016b) The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modeling approach. BMC Health Serv Res. https://doi.org/10.1186/s12913-016-1662-5CrossRefPubMedPubMedCentral

D’Addario M, Redmond S, Scott P et al (2017) Two-dose schedules for human papillomavirus vaccine: systematic review and meta-analysis. Vaccine 35:2892–2901. https://doi.org/10.1016/j.vaccine.2017.03.096CrossRefPubMed

Drummond M et al (1997) Methods for the economic evaluation of health care programs, 2nd edn. Oxford University Press, Oxford

Ekwunife OI, Lhachimi SK (2017) Cost-effectiveness of human papilloma virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and program coverage. BMC Health Serv Res. https://doi.org/10.1186/s12913-017-2758-2CrossRefPubMedPubMedCentral

Ezat SWP, Aljunid S (2010a) Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev 11:943–951PubMed

Ezat SWP, Aljunid S (2010b) Cost-effectiveness of HPV vaccination in the prevention of cervical cancer in Malaysia. Asian Pacific J Cancer Prev 11:79–90

Fesenfeld M, Hutubessy R, Jit M (2013) Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. Vaccine 31:3786–3804. https://doi.org/10.1016/j.vaccine.2013.06.060CrossRefPubMed

Fonseca AJD, Ferreira LCDL, Neto GB (2013) Cost-effectiveness of the vaccine against human papillomavirus in the Brazilian Amazon region. Rev Assoc Med Bras 59:442–451. https://doi.org/10.1016/j.ramb.2013.03.004CrossRefPubMed

Germar MJ, Purugganan C, Bernardino MS, Cuenca B (2017) Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule. Hum Vaccin Immunother. https://doi.org/10.1080/21645515.2016.1269991CrossRefPubMedPubMedCentral

Gervais F, Dunton K, Jiang Y, Largeron N (2017) Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend. BMC Public Health 17:1–18. https://doi.org/10.1186/s12889-017-4076-3CrossRef

Gomez JA, Lepetic A, Demarteau N (2014) Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model. BMC Public Health 14:1–13. https://doi.org/10.1186/1471-2458-14-1222CrossRef

Guerrero AM, Genuino AJ, Santillan M et al (2015) A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines. BMC Public Health 15:1–17. https://doi.org/10.1186/s12889-015-2046-1CrossRef

Haider S, Chaikledkaew U, Thavorncharoensap M et al (2019) Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofz117CrossRefPubMedPubMedCentral

International Monetary Fund Implied PPP conversion rate, https://www.imf.org/external/datamapper/PPPEX@WEO/OEMDC/ADVEC/WEOWORLD/HND. Accessed 27 Jan 2020

Kawai K, Tannus G, De Araujo B et al (2012) Estimated health and economic impact of in Brazil using a transmission dynamic model. BMC Infect Dis. https://doi.org/10.1186/1471-2334-12-250CrossRefPubMedPubMedCentral

Khatibi M, Reza H, Shahverdi Z, Reza H (2014) Cost-effectiveness evaluation of quadrivalent human papilloma virus vaccine for HPV-related disease in Iran. Iran J Pharm Res. 13:225–234PubMedPubMedCentral

Kiatpongsan S, Kim JJ (2014) Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries. PLoS ONE 9:1–6. https://doi.org/10.1371/journal.pone.0106836CrossRef

Kim JJ, Brisson M, Edmunds WJ, Goldie SJ (2008) Modeling cervical cancer prevention in developed countries. Vaccine 26:76–86. https://doi.org/10.1016/j.vaccine.2008.06.009CrossRef

Kim JJ, Campos NG, Shea MO et al (2013a) Model-based impact and cost-effectiveness of cervical cancer prevention in Sub-Saharan Africa. Vaccine 31:F60–F72. https://doi.org/10.1016/j.vaccine.2012.07.093CrossRefPubMed

Kim JJ, Sharma M, Shea MO et al (2013b) Model-based impact and cost-effectiveness of cervical cancer prevention in the extended middle East and North Africa (EMENA). Vaccine 31:G65–G77. https://doi.org/10.1016/j.vaccine.2012.06.096CrossRefPubMed

Kosen S, Andrijono A, Ocviyanti D (2017) The cost-effectiveness of quadrivalent human papillomavirus vaccination in Indonesia. Asian Pacific J Cancer Prev. https://doi.org/10.22034/APJCP.2017.18.7.2011CrossRef

Kostaras D, Karampli E, Athanasakis K (2019) Vaccination against HPV virus: a systematic review of economic evaluation studies for developed countries. Taylor & Francis 19:147–158. https://doi.org/10.1080/14737167.2019.1555039CrossRef

Kriekinge GV, Sohn W, Aljunid SM et al (2018) Comparative cost-effectiveness analysis of two different two-dose human papillomavirus vaccines in Malaysia. Asian Pac J Cancer Prev 19:933–940. https://doi.org/10.22034/APJCP.2018.19.4.933CrossRefPubMedPubMedCentral

Laprise JF, Drolet M, Boily MC et al (2014) Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. Vaccine 32:5845–5853. https://doi.org/10.1016/j.vaccine.2014.07.099CrossRefPubMed

Levin CE, Sharma M, Olson Z et al (2015) Vaccination to prevent cervical cancer in China. Vaccine. https://doi.org/10.1016/j.vaccine.2015.02.052CrossRefPubMedPubMedCentral

Li X, Stander MP, Van Kriekinge G, Demarteau N (2015) Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence. BMC Infect Dis. https://doi.org/10.1186/s12879-015-1295-zCrossRefPubMedPubMedCentral

Liu Y, Zhang Q, Hu S, Zhao F (2016) Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China. BMC Cancer. https://doi.org/10.1186/s12885-016-2207-3CrossRefPubMedPubMedCentral

Marseille E, Larson B, Kazi DS et al (2015) Thresholds for the cost–effectiveness of interventions: alternative approaches. Bull World Health Organ 93:118–124. https://doi.org/10.2471/BLT.14.138206CrossRefPubMed

Messoudi W, Elmahi T, Nejjari C et al (2019) Cervical cancer prevention in Morocco: a model- based cost-effectiveness analysis. J Med Econ. https://doi.org/10.1080/13696998.2019.1624556CrossRefPubMed

Mo X, Tobe RG, Wang L et al (2017) Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China. BMC Infect Dis. https://doi.org/10.1186/s12879-017-2592-5CrossRefPubMedPubMedCentral

Novaes HMD, Coelho P et al (2015) Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine 33:A135–A142. https://doi.org/10.1016/j.vaccine.2014.12.031CrossRefPubMed

Praditsitthikorn N, Teerawattananon Y, Tantivess S et al (2011) Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. Pharmacoeconomics 29:781–806. https://doi.org/10.2165/11586560-000000000-00000CrossRefPubMed

Prinja S, Bahuguna P, Faujdar DS, Jyani G (2017) Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: implications for India’ s universal immunization program. Cancer. https://doi.org/10.1002/cncr.30734CrossRefPubMed

Reynales-shigematsu LM, Rodrigues ER, Lazcano-ponce E (2009) Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico. Arch Med Res 40:503–513. https://doi.org/10.1016/j.arcmed.2009.08.004CrossRefPubMed

Setiawan D, Dolk FC, Suwantika AA et al (2016) Cost-utility analysis of human papillomavirus vaccination and cervical screening on cervical cancer patient in Indonesia. Value Heal Reg Issues 9:84–92. https://doi.org/10.1016/j.vhri.2015.10.010CrossRef

Sharma M, Ortendahl J, Van Der Ham E, Sy S (2011) Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand. An Int J Obstet Gynaecol. https://doi.org/10.1111/j.1471-0528.2011.02974.xCrossRef

Silas OA, Achenbach CJ, Murphy RL et al (2018) Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature. Expert Rev Vaccines 17:91–98. https://doi.org/10.1080/14760584.2018.1411195CrossRefPubMed

Sinanovic E, Moodley J, Barone MA et al (2009) The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa. Vaccine. https://doi.org/10.1016/j.vaccine.2009.08.004CrossRefPubMed

Sinisgalli E, Bellini I, Indiani L et al (2015) HPV vaccination for boys? A systematic review of economic studies. Epidemiol Prev 39:51–58PubMed

Termrungruanglert W, Havanond P, Khemapech N, Lertmaharit S (2012) Cost and effectiveness evaluation of prophylactic HPV vaccine in. Value Health 15:S29–S34. https://doi.org/10.1016/j.jval.2011.11.007CrossRefPubMed

The World Bank. GDP per capita (current US$). https://data.worldbank.org/indicator/NY.GDP.PCAP.CD. 27 Jan 2020

The World Bank GDP per capita (current US$). https://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 27 Jan 2020

Tracy JK, Schluterman NH, Greene C et al (2014) Planning for human papillomavirus (HPV) vaccination in sub-Saharan Africa: a modeling-based approach. Vaccine 32:3316–3322. https://doi.org/10.1016/j.vaccine.2014.03.067CrossRefPubMed

UNDP (2004) Forging a global south. https://www.undp.org/content/dam/china/docs/Publications/UNDP-CH-PR-Publications-UNDay-for-South-South-Cooperation.pdf. Accessed 3 Oct 2019

United States Department of Labor Bureau of Labor Statistics. Consumer price index, http://www.bls.gov/cpi/. Accessed 27 Jan 2020

Van Minh H, Thi N, My T, Jit M (2017) Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study. BMC Health Serv Res 17:1–7. https://doi.org/10.1186/s12913-017-2297-xCrossRef

Vu M, Yu J, Awolude OA, Chuang L (2018) Cervical cancer worldwide. Curr Probl Cancer 42:457–465. https://doi.org/10.1016/j.currproblcancer.2018.06.003CrossRefPubMed

Walwyn L, Bess C, David A, Prieto E (2015) Cost-effectiveness of HPV vaccination in Belize. Vaccine 33:A174–A181. https://doi.org/10.1016/j.vaccine.2014.12.042CrossRefPubMed

World Health Organization Immunization, Vaccines and biologicals. https://www.who.int/immunization/diseases/hpv/en/. Accessed 5 Jan 2020

Yaghoubi M, Nojomi M, Vaezi A et al (2018) Cost-effectiveness analysis of the introduction of HPV vaccination of 9-year-old-girls in Iran. Value Heal Reg Issues 15:112–119. https://doi.org/10.1016/j.vhri.2018.03.001CrossRef

Zhang Q, Liu Y, Hu S, Zhao F (2016) Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China. BMC Cancer. https://doi.org/10.1186/s12885-016-2893-xCrossRefPubMedPubMedCentral

Title: Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review
Authors: Saba Abidi
Satyanarayana Labani
Aastha Singh
Smita Asthana
Puneeta Ajmera
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Human Papillomavirus
Vaccination
Published in: International Journal of Public Health / Issue 7/2020
Print ISSN: 1661-8556
Electronic ISSN: 1661-8564
DOI: https://doi.org/10.1007/s00038-020-01431-1

At a glance: The STEP trials

Springer Medicine

Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2020

Emancipation versus normality in the Global South

Inventory of marketing techniques used in child-appealing food and beverage research: a rapid review

Identifying factors associated with obesity traits in undergraduate students: a scoping review

The influence of the sugar-sweetened beverage industry on public policies in Mexico

The psychosocial impact of flu influenza pandemics on healthcare workers and lessons learnt for the COVID-19 emergency: a rapid review

Commercial determinants of health: an ethical exploration